Revisiting protein acetylation and myocardial fatty acid oxidation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 313, Issue 3, 2017, Pages H617-H619

  Al Batran, Rami ^a,b   Ussher, John R ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; ACETYL COENZYME A; BUTYRYL COENZYME A DEHYDROGENASE; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; SIRTUIN 3; FATTY ACID; MITOCHONDRIAL PROTEIN;

AEROBIC METABOLISM; AMINO ACID SYNTHESIS; BROWN ADIPOSE TISSUE; EDITORIAL; ENERGY YIELD; ENZYME ACTIVITY; FATTY ACID OXIDATION; H9C2(2-1) CELL LINE; HEART FUNCTION; HUMAN; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SULFATION; SUMOYLATION; ACETYLATION; CARDIAC MUSCLE; OXIDATION REDUCTION REACTION;

ACETYLATION; FATTY ACIDS; MITOCHONDRIAL PROTEINS; MYOCARDIUM; OXIDATION-REDUCTION;

EID: 85029381251     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00303.2017     Document Type: Editorial

References (17)

1. Alrob OA, Sankaralingam S, Ma C, Wagg CS, Fillmore N, Jaswal JS, Sack MN, Lehner R, Gupta MP, Michelakis ED, Padwal RS, Johnstone DE, Sharma AM, Lopaschuk GD. Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling. Cardiovasc Res 103: 485-497, 2014. doi:10.1093/cvr/cvu156.
2. Bairoch A, Apweiler R. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Res 28: 45-48, 2000. doi:10.1093/nar/28.1.45.
3. Chen T, Liu J, Li N, Wang S, Liu H, Li J, Zhang Y, Bu P. Mouse SIRT3 attenuates hypertrophy-related lipid accumulation in the heart through the deacetylation of LCAD. PLoS One 10: e0118909, 2015. doi:10.1371/journal.pone.0118909.
4. He W, Newman JC, Wang MZ, Ho L, Verdin E. Mitochondrial sirtuins:regulators of protein acylation and metabolism. Trends Endocrinol Metab 23: 467-476, 2012. doi:10.1016/j.tem.2012.07.004.
5. Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S, Ilkayeva OR, Stevens RD, Li Y, Saha AK, Ruderman NB, Bain JR, Newgard CB, Farese RV Jr, Alt FW, Kahn CR, Verdin E. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464: 121-125, 2010. doi:10.1038/nature08778.
6. Hirschey MD, Shimazu T, Jing E, Grueter CA, Collins AM, Aouizerat B, Stančáková A, Goetzman E, Lam MM, Schwer B, Stevens RD, Muehlbauer MJ, Kakar S, Bass NM, Kuusisto J, Laakso M, Alt FW, Newgard CB, Farese RV Jr, Kahn CR, Verdin E. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol Cell 44: 177-190, 2011. doi:10.1016/j.molcel.2011.07.019.
7. Idell-Wenger JA, Grotyohann LW, Neely JR. Coenzyme A and carnitine distribution in normal and ischemic hearts. J Biol Chem 253: 4310-4318, 1978.
8. Khoury GA, Baliban RC, Floudas CA. Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database. Sci Rep 1: srep00090, 2011. doi:10.1038/srep00090.
9. Koentges C, Pfeil K, Schnick T, Wiese S, Dahlbock R, Cimolai MC, Meyer-Steenbuck M, Cenkerova K, Hoffmann MM, Jaeger C, Odening KE, Kammerer B, Hein L, Bode C, Bugger H. SIRT3 deficiency impairs mitochondrial and contractile function in the heart. Basic Res Cardiol 110: 36, 2015. doi:10.1007/s00395-015-0493-6.
10. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 90:207-258, 2010. doi:10.1152/physrev.00015.2009.
11. Menzies KJ, Zhang H, Katsyuba E, Auwerx J. Protein acetylation in metabolism-metabolites and cofactors. Nat Rev Endocrinol 12: 43-60, 2016. doi:10.1038/nrendo.2015.181.
12. Peterson LR, Herrero P, Schechtman KB, Racette SB, Waggoner AD, Kisrieva-Ware Z, Dence C, Klein S, Marsala J, Meyer T, Gropler RJ. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109: 2191-2196, 2004. doi:10.1161/01.CIR.0000127959.28627.F8.
13. Robishaw JD, Neely JR. Coenzyme A metabolism. Am J Physiol Endocrinal Metab 248: E1-E9, 1985.
14. Thapa D, Zhang M, Manning JR, Guimaraes D, Stoner M, O’Doherty RM, Shiva S, Scott I. Acetylation of mitochondrial proteins by GCN5L1 promotes enhanced fatty acid oxidation in the heart. Am J Physiol Heart Circ Physiol 313: H265-H274, 2017. doi:10.1152/ajpheart.00752.2016.
15. Ussher JR, Elmariah S, Gerszten RE, Dyck JR. The emerging role of metabolomics in the diagnosis and prognosis of cardiovascular disease. J Am Coll Cardiol 68: 2850-2870, 2016. doi:10.1016/j.jacc.2016.09.972.
16. Ussher JR, Fillmore N, Keung W, Mori J, Beker DL, Wagg CS, Jaswal JS, Lopaschuk GD. Trimetazidine therapy prevents obesityinduced cardiomyopathy in mice. Can J Cardiol 30: 940-944, 2014. doi:10.1016/j.cjca.2014.04.023.
17. Zlobine I, Gopal K, Ussher JR. Lipotoxicity in obesity and diabetesrelated cardiac dysfunction. Biochim Biophys Acta 1861: 1555-1568, 2016. doi:10.1016/j.bbalip.2016.02.011.